Search - tctmd.com

Displaying 61 - 80 of 1120

Sort: Relevancy | Date

Presentation TCT 2016

Transfemoral Large Hole Closure Devices: Manta, Inseal, and Others

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Alexandre Abizaid

November 01, 2016

Presentation TCT 2016

Experience With the Balloon Expandable Valves

Presenter: Ziyad M. Hijazi, David W.M. Muller, Imad A. Alhaddad

November 01, 2016

Presentation TCT 2016

Transcatheter Tricuspid Valve Therapies 5: Millipede Description, Results and a Case

Presenter: Joachim Schofer, Alec S. Vahanian, Jason H. Rogers

November 01, 2016

Presentation TCT 2016

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Presenter: Eustaquio Maria Onorato, Richard Smalling, David E. Thaler

November 01, 2016

Presentation TCT 2016

Assessment and Implications of Residual Leaks After Percutaneous and Surgical LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw

November 01, 2016

Presentation TCT 2016

Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs. Societal Economic Considerations

Presenter: Aaron V. Kaplan, Rachel Neubrander, Tamara Syrek Jensen

November 01, 2016

Presentation TCT 2016

Transcatheter Tricuspid Valve Therapies 4: Tricuspid MitraClip Procedure, Results and a Case

Presenter: Joachim Schofer, Alec S. Vahanian

November 01, 2016

Presentation TCT 2016

Valve Selection for TAVR: Similarities and Differences; How to Choose

Presenter: Ziyad M. Hijazi, David W.M. Muller, Mohamed Chettibi

November 01, 2016

Presentation TCT 2016

New Valvuloplasty Devices III: Bard TRUE and TRUE-Flow Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Cheng-Han Chen

November 01, 2016

Presentation TCT 2016

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Presenter: Eustaquio Maria Onorato, Richard Smalling

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Follow-up Evaluation After LAA Closure

Presenter: David R. Holmes Jr., Jacqueline Saw, Bushra S Rana

November 01, 2016

Presentation TCT 2016

Transcatheter Tricuspid Valve Therapies 3: Forma Description, Results and a Case

Presenter: Joachim Schofer, Alec S. Vahanian, Josep Rodés-Cabau

November 01, 2016

Presentation TCT 2016

Role of Echocardiography in TAVR

Presenter: Ziyad M. Hijazi, David W.M. Muller, Muhamed Saric

November 01, 2016

Presentation TCT 2016

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives

Presenter: Aaron V. Kaplan, Rachel Neubrander, Brian K. Whisenant

November 01, 2016

Presentation TCT 2016

New Valvuloplasty Devices II: InterValve V8 Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Wesley R. Pedersen

November 01, 2016

Presentation TCT 2016

Transcatheter Tricuspid Valve Therapies 2: 4-Tech Description, Results and a Case

Presenter: Joachim Schofer, Alec S. Vahanian

November 01, 2016

Presentation TCT 2016

Preinterventional Selection of Patients: What Tests Must Be Done Prior to TAVR?

Presenter: Ziyad M. Hijazi, David W.M. Muller, Clifford J. Kavinsky

November 01, 2016

Presentation TCT 2016

New Valvuloplasty Devices I: Pi-cardia Leaflex Aortic Valve Remodeling Therapy

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Michael Jonas

November 01, 2016

Presentation TCT 2016

Transcatheter Tricuspid Valve Therapies 1: Trialign Description, Results and a Case

Presenter: Joachim Schofer, Alec S. Vahanian, Rebecca T. Hahn

November 01, 2016

Advertisement

Transfemoral Large Hole Closure Devices: Manta, Inseal, and Others

Experience With the Balloon Expandable Valves

Transcatheter Tricuspid Valve Therapies 5: Millipede Description, Results and a Case

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Assessment and Implications of Residual Leaks After Percutaneous and Surgical LAA Closure

Reimbursement Challenges For LAAC: Balancing The Clinical Need Vs. Robust Data Vs. Societal Economic Considerations

Transcatheter Tricuspid Valve Therapies 4: Tricuspid MitraClip Procedure, Results and a Case

Valve Selection for TAVR: Similarities and Differences; How to Choose

New Valvuloplasty Devices III: Bard TRUE and TRUE-Flow Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Anticipating FDA approval of the Amplatzer PFO Occluder: Indications, Rational Dispersion of Technology, and Post-Approval Studies

Highlights (and my Interpretations) From: RESPECT Final Long-term Outcomes

Follow-up Evaluation After LAA Closure

Transcatheter Tricuspid Valve Therapies 3: Forma Description, Results and a Case

Role of Echocardiography in TAVR

Pivotal Trial Design Considerations: Noninferiority vs Superiority, Device, Control Arm Anticoagulation Durations, NOAC Considerations and More Industry and Clinician Perspectives

New Valvuloplasty Devices II: InterValve V8 Balloon Valvuloplasty - Technical Advantages and Clinical Applications

Transcatheter Tricuspid Valve Therapies 2: 4-Tech Description, Results and a Case

Preinterventional Selection of Patients: What Tests Must Be Done Prior to TAVR?

New Valvuloplasty Devices I: Pi-cardia Leaflex Aortic Valve Remodeling Therapy

Transcatheter Tricuspid Valve Therapies 1: Trialign Description, Results and a Case

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content